Allied Market Research

2025

Generic Medicine Market

Generic Medicine Market, by Prescription-Based Medicines (Branded Medicines, Generic Medicines) and, by Over-the-Counter (OTC) Medicines (OTC Competitive-Pricing drugs, OTC Branded Medicines): Opportunity Analysis and Industry Forecast, 2023-2032

LS : Other

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

The study on the Generic medicine market offers insights, information, and recommendation to market stakeholders and investors to help them prioritize and formulate strategic decisions. The report includes Generic medicine market across more than 15 countries. The study is analyzed on the basis of rigorous research methodology, which covers extensive desk research using qualitative analysis, quantitative/statistical methods, and primary interviews.

The study analyzes the market scope, revenue size, and growth of the global Generic medicine market and monitors the prime trends at the regional level. In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies. The report includes a section on the company profile that covers the company overview, company snapshot, key executives, product/service portfolio, operating business segments, business performance, R&D expenditure, and key strategic moves & developments. The global Generic medicine market is categorized on the basis of by prescription-based medicines, by over-the-counter (otc) medicines. On the basis of region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Spain, Italy, and rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).

Key players covered in this report are Pfizer, Bayer Pharmaceuticals, GlaxoSmithKline, Bristol-Myers Squibb, Sanofi-Aventis, Novartis Pharma, AstraZeneca Pharmaceuticals, Abbott Laboratories, Roche Holding, Merck and Co

Deliverables:

  • Market size value forecast by country

  • Regional-level market trends and market dynamics

  • Porter’s five forces model and PESTLE Analysis

  • Company profile, competition landscape inclusive of heatmap analysis, competition dashboard and product/service offerings

  • Major developmental strategies and M&A activities

  • Country-wise market size and forecast for each segment

  • Market share of leading players worldwide

Market Taxonomy

This report divides the global Generic medicine market on the basis of by prescription-based medicines, by over-the-counter (otc) medicines. On the basis of region, the global Generic medicine market analyzed across North America; Europe; Asia-Pacific; and Latin America, the Middle East, and Africa.

Generic Medicine Market, by Prescription-Based Medicines Report Highlights

Aspects Details
icon_5
By Prescription-Based Medicines
  • Branded Medicines
  • Generic Medicines
icon_6
By Over-the-Counter (OTC) Medicines
  • OTC Competitive-Pricing drugs
  • OTC Branded Medicines
icon_7
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
icon_8
Key Market Players

Roche Holding, GlaxoSmithKline, Sanofi-Aventis, Bayer Pharmaceuticals, Novartis Pharma, Pfizer, AstraZeneca Pharmaceuticals, Abbott Laboratories, Bristol-Myers Squibb, Merck and Co

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Generic Medicine Market, by Prescription-Based Medicines

Opportunity Analysis and Industry Forecast, 2023-2032